Profile
ABEO VRTX REGN SGEN ALNY ARGX
Company Name Abeona Therapeutics Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $301.31M $116.96B $54.11B $43.15B $38.15B $33.66B
Employees 0.14K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Dr. Vishwas Seshadri M.B.A., Ph.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
Trading
ABEO VRTX REGN SGEN ALNY ARGX
Last Close $5.98 $445.82 $520.29 $228.74 $321.94 $560.53
High 52 $6.86 $516.74 $1201.76 $228.74 $325 $671.75
Low 52 $4.09 $396.64 $482.92 $228.74 $224.58 $430.04
Price vs. 52 Week High -12.83 % -13.72 % -56.71 % 0 % -0.94 % -16.56 %
Price vs. 52 Week Low 46.21 % 12.4 % 7.74 % 0 % 43.35 % 30.34 %
Total Return
ABEO VRTX REGN SGEN ALNY ARGX
1 Month Return -6.85 % 2.25 % -11.57 % 0 % 11.03 % -4.61 %
3 Month Return 19.84 % -10.89 % -18.72 % 0 % 19.59 % -3.96 %
6 Month Return 4.55 % 8.56 % -27.4 % 0 % 32.76 % -11.31 %
9 Month Return 0.84 % -3.74 % -49.97 % 0 % 17.25 % 6.85 %
YTD Return 7.36 % 10.71 % -26.96 % 0 % 36.82 % -8.86 %
1 Year Return 46.21 % -5.95 % -51.34 % 0 % 31.31 % 25.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABEO VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.35 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -19.18 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
ABEO VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -44.47 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -86.45 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -85.53 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 63.48 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -249.74 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 0.33 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM - 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -1.2 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -1.27 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 169.06 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 105.21 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -249.74 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -4.78 -92.97 17.92 -81.26 -506.05 -433.65
Price To Operating Cash Flows Ratio TTM -4.9 -119.36 13.76 -93.1 -841.05 -515.25
Price Cash Flow Ratio TTM -4.9 -119.36 13.76 -93.1 -841.05 -515.25
Income Statement (TTM)
ABEO VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $-0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.06B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.06B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -1.55 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
ABEO VRTX REGN SGEN ALNY ARGX
Long Term Debt $0.02B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.06B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0.04B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0.07B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0.02B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.11B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
ABEO VRTX REGN SGEN ALNY ARGX
Net Income $-0.06B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.67
AARD Aardvark Therapeutics, Inc. Common Stock 13.95
ABCL AbCellera Biologics Inc. 3.7376
ABCM Abcam plc 23.99
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.225
ABPWW 0.0292
ABSI Absci Corporation 2.71
ABUS Arbutus Biopharma Corporation 3.195
ABVC ABVC BioPharma, Inc. 2.175
ABVX Abivax SA American Depositary Shares 7.15
ACAD ACADIA Pharmaceuticals Inc. 22.22
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6714
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.49
ACIU AC Immune SA 2.095
ACLX Arcellx, Inc. 64.835
ETFs With Exposure to ABEO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 302.04
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00096 133.77
VXF Vanguard Extended Market Index Fund 0 191.48
IWC iShares Micro-Cap ETF 0.06004 127.655
XAW.TO iShares Core MSCI All Country World ex Canada Index ETF 0 45.8
XUU.TO iShares Core S&P U.S. Total Market Index ETF 0 61.55
XUH.TO iShares Core S&P U.S. Total Market Index ETF (CAD-Hedged) 0 49.87
XTR.TO iShares Diversified Monthly Income ETF 0 11.295
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 101.78
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 101.77
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 49.45
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 49.44
VBINX Vanguard Balanced Index Fund Investor Shares 0 49.44
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0 34.1348
XBAL.TO iShares Core Balanced ETF Portfolio 0 30.87
XCNS.TO iShares Core Conservative Balanced ETF Portfolio 0 23.98
XEQT.TO iShares Core Equity ETF Portfolio 0 35.21
XGRO.TO iShares Core Growth ETF Portfolio 0 31.5
XINC.TO iShares Core Income Balanced ETF Portfolio 0 20.62
DFAT Dimensional U.S. Targeted Value ETF 0 53.885
DFAS Dimensional U.S. Small Cap ETF 0.00020616 63.57
DFAC Dimensional U.S. Core Equity 2 ETF 0 35.55
VTSAX Vanguard Total Stock Market Index Fund 0 145.69
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 143.65
VITSX Vanguard Total Stock Market Index Fund 0 145.72
IBRN iShares Neuroscience and Healthcare ETF 0.54924 22.2351
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000165995 102.76
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 143.66
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
JKL iShares Morningstar Small-Cap Value ETF 0 172.726
SURI Simplify Propel Opportunities ETF 4.68145 15.4681
VEMPX Vanguard Extended Market Index InstlPlus 0 354.51
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 273.35
Unlock